Daily Roundup

WHC.ASX MND.ASX TLX.ASX SEQ.ASX WAK.ASX

Whitehaven Secures $600 Million Syndicated Facility

Whitehaven Coal has secured a new $600 million syndicated facility, consisting of a $475 million term loan and a $125 million revolving credit facility. This new facility enhances the company's liquidity, extends its debt maturity profile, and reduces its funding cost. The facility was well-supported by lenders, reflecting confidence in Whitehaven's strong credit profile and disciplined financial management. The company plans to use the facility to repay a portion of its existing acquisition term loan and replace its existing $100 million revolving credit facility.

Monadelphous Wins $145 Million in New Contracts

Engineering company Monadelphous Group Limited has announced the award of new construction and maintenance contracts and contract extensions in the resources sector valued at approximately $145 million. The company has secured a contract with Rio Tinto for a project at the Paraburdoo iron ore mine, as well as two-year extensions to its existing maintenance services contracts with BHP and Queensland Alumina. Additionally, Monadelphous has been awarded a contract with Harmony Gold for the construction of a Cyclone Dewatering Plant in Papua New Guinea.

Telix's Glioma Imaging Agent Accepted for FDA Review

Telix Pharmaceuticals announced that the U.S. FDA has accepted the company's resubmitted New Drug Application for TLX101-Px (Pixclara), an investigational PET agent for the imaging of glioma (brain cancer). The FDA has assigned a PDUFA goal date of September 11, 2026. TLX101-Px has been granted Orphan Drug and Fast Track designations, and its approval will help address a significant unmet medical need for the characterization of recurrent or progressive glioma.

Sequoia Provides Update on InterPrac Disposal

Sequoia Financial Group Ltd has provided an update on the proposed disposal of its subsidiary InterPrac Financial Planning Pty Ltd to Conquest Investment Partners Pty Ltd. The company confirms that the Australian Securities and Investments Commission (ASIC) has commenced court proceedings to seek the appointment of a receiver over certain property of InterPrac, namely the guarantees in the ASIC cross deed of guarantee. Sequoia believes ASIC's concerns about the sale are unfounded and remains committed to progressing the transaction.

WA Kaolin Notifies Breach of ASX Listing Rule

WA Kaolin Ltd has notified that its 2026 offtake agreement with Dak Tai Trading Limited (DTT) breached ASX Listing Rule 10.1, as DTT is an associate of former director Sean Hu. The company has agreed to suspend the agreement and will seek shareholder approval at a meeting by mid-May 2026. In the meantime, WA Kaolin will continue to sell kaolin product to DTT on arm's length, ad hoc terms.